About Short stature due to growth hormone qualitative anomaly
Short stature due to growth hormone qualitative anomaly is a rare disease catalogued by Orphanet (ORPHA:629). It is associated with the GH1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Short stature due to growth hormone qualitative anomaly trials.
Search ClinicalTrials.gov for "Short stature due to growth hormone qualitative anomaly" or filter by Orphanet code ORPHA:629 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Short stature due to growth hormone qualitative anomaly trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Short stature due to growth hormone qualitative anomaly. Updated daily.